My Account - Logout - Upgrade Gold Membership - Update Company Informations

Add Favorites - Make Us Your Home Page


Home | Add Your Company | E-Katalog | Trade Leads | Turkçe Deutsch Gold Members
    Select Country
Services - Banner - Statistics - About Us - FAQ - Contact Us - Links

Turkey
Company Search:
Product-Service :
 Medical Materials
    BOLISE CO. LIMITED   

Company Home
About Us
Products & Services
E-Catalog Products
Contact
News
      E-Catalog Products & Services
      SEMAGLUTIDE
      Category : Medicine Chemicals


    Sequence:
    H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
    CAS NO.: 910463-68-2
    Molecular Formula: C187H291N45O59
    Molecular Weight: 4,113.64
    Appearance:White Crystalline Powder
    Purity: 99.38%
    Identification: Infrared Absorption
    Loss On Drying: ≤0.2%
    Residue On Ignition: ≤0.3%
    Chloride:≤0.05%
    Sulfate:≤0.03%
    Heavy - metals:≤0.0015%
    Application:
    1. Used as both injection-type or oral-type drug.
    2. Used for the treatment of obesity.
    3. Improve cardiovascular function
    4. Treatment of type 2 diabetes in adults
    About Semaglutide:
    Semaglutide(Ozempic) is a glucagon-like peptide-1 analogue for once-weekly subcutaneous treatment of type 2 diabetes.Semaglutide is a pharmaceutical drug which is used for the treatment of type 2 diabetes. Semaglutide has demonstrated the potential to improve the treatment of type 2 diabetes and the positive recommendation from the Advisory Committee marks an important step towards making semaglutide available to adults with type 2 diabetes in the US. Semaglutide(Ozempic), a newly once-weekly glucagon like peptide-1 (GLP-1) receptor agonist, has showed a favorable effect on glycaemic control and weight reduction in type 2 diabetes mellitus (T2DM).
    In humans semaglutide is chemically similar to glucagon-like peptide-1 (GLP-1).
    Semaglutide is a glucagon-like peptide-1 (GLP-1) analog and functions as a GLP-1 agonist.
    Furthermore, semaglutide demonstrated a significant, beneficial effect on cardiovascular outcomes and a safety profile similar to that of other GLP-1 receptor agonists.Semaglutide also improves cardiovascular function, reduces the risk of stroke by 39%, and reduces the risk of myocardial infarction by 26%.
      Other E-Catalog Products & Services


    E-Catalogue service is not active !!
    Service is for GOLD members only !!


      Contact Information
      299 Hudong Rd   361001   Xiamen  / China
    Tel : 18965162351    Fax :        

    Url : http://www.bkherb.com
    E-mail :
    Contact Person : bkherb   bkherb   / 


Last Update: 19.11.2018
To update to this company information.Please Login


All the information is provided by the company itself.
Turkindex- Telmar shall NOT guarantee the accuracy of these informations.
Turkindex- Telmar shall however not be held responsible for any inaccuracy in the company information.


Text Linkler
Sector Search:
|Home Page| Add New Company |Our Services|Banner|About Us|Contact Us|Help|


Terms of Use | Privacy
Copy Right Telmar Communication Services A.Ş.
Telmar©-1997-2024 - İstanbul | info@telmar.com.tr

http://www.TurkFreeZone.Com.Com - http://www.list2000.com - Classified ads